Abridge's primary go-to-market advantage stems from giving Epic both an equity stake and ongoing revenue share, securing preferential access to 38% of all hospital networks that use Epic, positioning them as the default AI scribe in Epic-owned systems like Mayo, Kaiser, and Duke. The company plans to use funding as of 2026-07-27 to transform clinical documentation and revenue cycle workflows by scaling its platform to provide revenue cycle intelligence earlier in clinical conversations and eliminate the need for manual and delayed coordination between clinicians and billing teams.
Cyborg Score Rationale
Abridge raised a $300 million Series E round in June 2025 at a $5.3 billion post-money valuation, marking a nearly twofold increase in valuation in just four months. The company's technology has been deployed in more than 150 health systems, a 50% increase from its Series D announcement just four months prior. Strong market momentum, enterprise adoption, and strategic Epic integration position Abridge as the category leader in ambient AI clinical documentation.
Top Insights
In Q1 2025, Abridge reached $117 million in contracted annual recurring revenue (a metric that includes all signed recurring contracts, including from customers that have still not been onboarded). This signals strong enterprise demand and signals significant future revenue recognition.
Abridge was named KLAS #1 Market Leader for Ambient AI in Revenue Cycle Management for the second consecutive year in February 2026. This reinforces competitive moat and validates expansion into revenue cycle workflows.
Abridge has raised a total of $778M over 8 rounds from 37 investors. This well-capitalized position enables aggressive R&D and customer acquisition to defend leadership in a crowded field.
Named Competitors
Ambience — Ambient AI clinical documentation with medical coding support
Suki — AI clinical assistant for note generation, coding recommendations, and medical Q&A
DeepScribe — Ambient AI medical scribe platform
Tandem Health — Ambient AI clinical documentation platform
Nabla — AI assistant for clinical documentation with international reach and strong comparative research
Heidi Health — AI medical scribe with product-led model and broad international clinician adoption
Recent Developments
(February 2026) Named KLAS #1 Market Leader for Ambient AI in Revenue Cycle Management for second consecutive year
(January 2026) Partnership with Availity to automate prior authorization at the point of conversation
(June 2025) Raised $300 million Series E funding led by Andreessen Horowitz at $5.3B valuation
(February 2025) Raised $250 million Series D funding at $2.8B valuation with participation from Alphabet's CapitalG and NVIDIA's NVentures
Open the full interactive Abridge report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.